Molecular Tumor Board: 56-year-old with endometrial cancer and POLE V411L alteration

Uterine cancer is the most common gynecologic cancer in the US, with increasing incidence and mortality rate. This Molecular Tumor Board case presented is about a 56-year-old female patient with uterine cancer and an underlying POLE V411L alteration. Join us as we discuss molecular subgroups in uterine cancer and how molecular classification impacts targeted therapy options.